EndoAnchors辅助EVAR术后早期主动脉瘤颈扩张的预测因素
本研究基于ANCHOR研究257例接受Heli-FX EndoAnchor植入的EVAR患者,分析术后1个月及1年内不同瘤颈水平的扩张预测因素。多因素回归显示基线瘤颈直径和移植物oversizing是早期瘤颈扩张的独立危险因素,而EndoAnchor在其常规部署水平具有保护作用。
要点
- 基线瘤颈直径和移植物oversizing是早期瘤颈扩张的独立危险因素。
- EndoAnchor在其常规部署水平对瘤颈扩张具有保护作用。
- 肾下5mm水平≥3mm扩张在围术期发生率为12.5%,1个月至1年为8.1%。
核心结论
- 主动脉直径和移植物oversizing似乎是早期主动脉瘤颈扩张的独立危险因素。
- EndoAnchor在其常规部署水平对瘤颈扩张具有保护作用。
研究设计与样本
- ANCHOR研究为前瞻性队列,纳入2012年4月至2014年9月38个中心的257例连续患者。
- 仅纳入初次EVAR时植入EndoAnchor的患者(初次治疗组)。
- 在肾上水平及近端瘤颈内三个水平测量主动脉直径。
- 209例有基线和1个月CT影像,62例有1个月和1年CT影像(平均11.9±4.0个月)。
- 多因素分析纳入6个候选变量、6个临床变量和14个解剖变量,在八个模型中运行。
主要发现
- 1个月时瘤颈扩张在最低肾动脉下0mm、5mm、10mm处分别为0.2±1.7mm、0.7±2.2mm、0.9±3.6mm,肾上水平为0.0±1.5mm。
- 1个月至1年时上述四个水平扩张分别为0.5±1.6mm、0.4±1.5mm、0.2±1.8mm和-0.3±1.1mm。
- 最低肾动脉下5mm水平≥3mm扩张在术前至1个月见于26例(12.5%),1个月至1年见于5例(8.1%)。
- 围术期瘤颈扩张的预测变量包括基线瘤颈直径、附壁钙化(保护性)和带肾上支架的移植物。
- 1个月至1年瘤颈扩张与基线瘤颈直径、瘤颈长度(保护性)、瘤颈角度、装置oversizing、EndoAnchor数量(保护性)和带肾上支架的移植物相关。
临床怎么用
- 对基线瘤颈直径较大或移植物oversizing程度较高的EVAR患者,应加强术后瘤颈扩张监测。
- EndoAnchor在其常规部署水平可能有助于减缓瘤颈扩张,可考虑在该水平使用。
局限性
- 1个月至1年分析仅纳入62例有随访CT影像的患者,样本量较小。
- 研究为单臂前瞻性队列,未设未使用EndoAnchor的对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Dilatation of the aorta within the proximal neck after endovascular aneurysm repair (EVAR) can be associated with late endoleaks and migration. This study was designed to identify predictors of early neck dilation in patients undergoing EVAR with Heli-FX EndoAnchors (Medtronic, Santa Rosa, Calif) measured perioperatively to 1 year at different longitudinal levels of neck length. METHODS: The study group of Aneurysm Treatment Using the Heli-FX Aortic Securement System (ANCHOR) comprises 257 consecutive patients prospectively enrolled between April 2012 and September 2014 undergoing EVAR with Heli-FX EndoAnchor implantation at 38 investigational sites. Only patients undergoing EndoAnchor implantation at the time of the initial EVAR were included (primary treatment arm). Aortic diameter was measured at the suprarenal level and at three levels within the proximal neck. Neck dilatation was assessed in 209 patients with adequate computed tomography imaging at baseline and 1 month and in 62 patients at 1 month and 1 year (mean, 11.9 ± 4.0 months). Multivariable analyses were performed to identify independent predictors of perioperative (baseline to 1 month) and early postoperative (1 month to 1 year) aortic dilation at each level; analyses included 6 candidate variables, 6 clinical, and 14 anatomic run in eight models (one at each of the four aortic levels for both time frames). RESULTS: The mean aortic neck dilation at 1 month was 0.2 ± 1.7 mm, 0.7 ± 2.2 mm, and 0.9 ± 3.6 mm at 0 mm, 5 mm, and 10 mm below the lowest renal artery, and 0.0 ± 1.5 mm at the suprarenal level. From 1 month to 1 year, neck dilatation was 0.5 ± 1.6 mm, 0.4 ± 1.5 mm, 0.2 ± 1.8 mm, and -0.3 ± 1.1 mm at the same four levels, respectively. Dilatation of ≥3 mm at level 5 mm distal to the lowest renal artery was observed in 26 patients (12.5%) from preoperative to 1 month and in 5 patients (8.1%) between 1 month and 1 year. Multivariable regression identified several variables predictive of perioperative (preoperative to 1 month) neck dilatation: baseline neck diameter, mural calcium (protective), and endografts with a suprarenal stent. Neck dilatation between 1 month and 1 year was associated with baseline neck diameter, neck length (protective), neck angulation, device oversizing, number of EndoAnchors implanted (protective), and endografts with a suprarenal stent. CONCLUSIONS: Aortic diameter and graft oversizing appear to be independent risk factors for early aortic neck dilatation. EndoAnchors have a protective effect on neck dilatation at their usual level of deployment.
引用
- Tassiopoulos AK, Monastiriotis S, Jordan WD, et al. Predictors of early aortic neck dilatation after endovascular aneurysm repair with EndoAnchors. J Vasc Surg. 2017. PMID: 28274751. doi:10.1016/j.jvs.2016.12.117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。